| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Atacicept in patients with rheumatoid arthritis: results of a multicenter, phase Ib, double-blind, placebo-controlled, dose-escalating, single- and repeated-dose study.
|
Arthritis Rheum
|
2008
|
1.38
|
|
2
|
Pharmacokinetics and pharmacodynamics of recombinant human chorionic gonadotrophin in healthy male and female volunteers.
|
Reprod Biomed Online
|
2002
|
1.13
|
|
3
|
Pharmacokinetic and pharmacodynamic interactions between recombinant human luteinizing hormone and recombinant human follicle-stimulating hormone.
|
Fertil Steril
|
1998
|
1.09
|
|
4
|
Pharmacokinetics and pharmacodynamics of IFN-beta 1a in healthy volunteers.
|
J Interferon Cytokine Res
|
2000
|
1.09
|
|
5
|
Influence of interferon beta-1a dose frequency on PBMC cytokine secretion and biological effect markers.
|
J Neuroimmunol
|
1999
|
1.09
|
|
6
|
Trimethoprim, alone or in combination with sulphamethoxazole, decreases the renal excretion of zidovudine and its glucuronide.
|
Br J Clin Pharmacol
|
1992
|
1.08
|
|
7
|
Sinistrin clearance for determination of glomerular filtration rate: a reappraisal of various approaches using a new analytical method.
|
J Clin Pharmacol
|
1997
|
1.07
|
|
8
|
Disposition and irreversible plasma protein binding of tolmetin in humans.
|
Clin Pharmacol Ther
|
1988
|
0.91
|
|
9
|
Leukemia inhibitory factor in human reproduction.
|
Fertil Steril
|
2001
|
0.90
|
|
10
|
The population pharmacokinetics of recombinant- and urinary-human follicle stimulating hormone in women.
|
Br J Clin Pharmacol
|
1998
|
0.89
|
|
11
|
Clinical pharmacology of recombinant human luteinizing hormone: Part I. Pharmacokinetics after intravenous administration to healthy female volunteers and comparison with urinary human luteinizing hormone.
|
Fertil Steril
|
1998
|
0.88
|
|
12
|
Whole-blood pharmacokinetics and metabolic effects of the topical carbonic anhydrase inhibitor dorzolamide.
|
Eur J Clin Pharmacol
|
1995
|
0.87
|
|
13
|
Pharmacokinetics and immunoglobulin response of subcutaneous and intravenous atacicept in patients with systemic lupus erythematosus.
|
J Pharm Sci
|
2010
|
0.85
|
|
14
|
Modeling a bivariate control system: LH and testosterone response to the GnRH antagonist antide.
|
Am J Physiol
|
1996
|
0.84
|
|
15
|
Once-a-week azithromycin in AIDS patients: tolerability, kinetics, and effects on zidovudine disposition.
|
Antimicrob Agents Chemother
|
1992
|
0.83
|
|
16
|
Fractional excretion of trace lithium and uric acid in acute renal failure.
|
J Am Soc Nephrol
|
1994
|
0.83
|
|
17
|
Clinical experience with angiotensin II receptor antagonists.
|
Am J Hypertens
|
1992
|
0.82
|
|
18
|
Clinical pharmacology of recombinant human luteinizing hormone: Part II. Bioavailability of recombinant human luteinizing hormone assessed with an immunoassay and an in vitro bioassay.
|
Fertil Steril
|
1998
|
0.82
|
|
19
|
Down-regulation models and modeling of testosterone production induced by recombinant human choriogonadotropin.
|
J Pharmacol Exp Ther
|
1999
|
0.79
|
|
20
|
A population model for the follicular growth in women treated with follicle stimulating hormone.
|
Clin Pharmacol Ther
|
1997
|
0.78
|
|
21
|
Effect of the renin response during renin inhibition: oral Ro 42-5892 in normal humans.
|
J Cardiovasc Pharmacol
|
1991
|
0.78
|
|
22
|
Prevention of arrhythmias after noncardiac thoracic operations: flecainide versus digoxin.
|
Ann Thorac Surg
|
1991
|
0.76
|
|
23
|
Determination of partial solubility parameters of lactose by gas-solid chromatography.
|
J Pharm Sci
|
1986
|
0.75
|
|
24
|
[The treatment of cardiac insufficiency with vasodilators].
|
Schweiz Med Wochenschr
|
1988
|
0.75
|
|
25
|
[Value of simultaneous determination of cyclosporin blood levels using specific and nonspecific methods in liver transplantation].
|
Schweiz Med Wochenschr
|
1992
|
0.75
|
|
26
|
Absence of metabolic effects of the topical carbonic anhydrase inhibitors MK-927 and sezolamide during two-week ocular administration to normal subjects.
|
Clin Pharmacol Ther
|
1991
|
0.75
|
|
27
|
A preliminary evaluation of the discriminative power of the monoethylglycinexylidide formation test after intravenous and oral administration of lidocaine.
|
Transplant Proc
|
2001
|
0.75
|
|
28
|
Renal effects of nimesulide in furosemide-treated subjects.
|
Drugs
|
1993
|
0.75
|
|
29
|
Rapid high-performance liquid chromatographic determination with fluorescence detection of furosemide in human body fluids and its confirmation by gas chromatography-mass spectrometry.
|
J Chromatogr
|
1991
|
0.75
|
|
30
|
[Evaluation and intervention in demented patients: capacity approach or deficiency approach?].
|
Acta Psiquiatr Psicol Am Lat
|
1994
|
0.75
|
|
31
|
Effect of pH on acyl migration and hydrolysis of tolmetin glucuronide.
|
Drug Metab Dispos
|
1988
|
0.75
|
|
32
|
Safety, pharmacokinetics and pharmacodynamics of recombinant human tumour necrosis factor-binding protein-1 (Onercept) injected by intravenous, intramuscular and subcutaneous routes into healthy volunteers.
|
Eur Cytokine Netw
|
2001
|
0.75
|